A detailed history of Latitude Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Latitude Advisors, LLC holds 1,264 shares of LLY stock, worth $1.14 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
1,264
Previous 1,290 2.02%
Holding current value
$1.14 Million
Previous $1 Million 14.06%
% of portfolio
0.81%
Previous 0.73%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $18,846 - $23,635
-26 Reduced 2.02%
1,264 $1.14 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $9,475 - $12,676
16 Added 1.26%
1,290 $1 Million
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $31,511 - $37,147
60 Added 4.94%
1,274 $742,000
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 Added 2.53%
1,214 $652,000
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $122,057 - $163,205
348 Added 41.63%
1,184 $555,000
Q1 2023

Apr 27, 2023

SELL
$310.63 - $364.82 $59,951 - $70,410
-193 Reduced 18.76%
836 $287,000
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $161,739 - $188,459
-503 Reduced 32.83%
1,029 $0
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $5,336 - $6,081
18 Added 1.19%
1,532 $495,000
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $891,657 - $1.05 Million
-3,199 Reduced 67.88%
1,514 $490,000
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $27,458 - $34,124
117 Added 2.55%
4,713 $1.35 Million
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $77,348 - $95,989
344 Added 8.09%
4,596 $1.27 Million
Q3 2021

Oct 14, 2021

BUY
$221.6 - $272.71 $483,974 - $595,598
2,184 Added 105.61%
4,252 $982,000
Q2 2021

Jul 20, 2021

BUY
$180.55 - $233.54 $11,735 - $15,180
65 Added 3.25%
2,068 $475,000
Q1 2021

Apr 14, 2021

BUY
$164.32 - $212.72 $131,784 - $170,601
802 Added 66.78%
2,003 $374,000
Q4 2020

Feb 04, 2021

BUY
$130.46 - $172.63 $156,682 - $207,328
1,201 New
1,201 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $854B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Latitude Advisors, LLC Portfolio

Follow Latitude Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.